News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
64,216 Results
Type
Article (3774)
Company Profile (7)
Press Release (60435)
Section
Business (20130)
Career Advice (115)
Deals (2442)
Drug Delivery (17)
Drug Development (7541)
Employer Resources (11)
FDA (1492)
Job Trends (1832)
News (31392)
Policy (2357)
Tag
2024 BioForest Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (548)
Adcomms (1)
Allergies (12)
Alliances (5436)
ALS (6)
Alzheimer's disease (275)
Antibody-drug conjugate (ADC) (6)
Approvals (1509)
Artificial intelligence (34)
Autoimmune disease (1)
Automation (1)
Bankruptcy (14)
Best Places to Work (1687)
Biosimilars (5)
Biotechnology (5)
Bladder cancer (6)
Brain cancer (1)
Breast cancer (32)
Cancer (258)
Cardiovascular disease (25)
Career advice (103)
Career pathing (5)
CAR-T (9)
Cell therapy (47)
Cervical cancer (3)
Clinical research (6063)
Collaboration (125)
Compensation (2)
COVID-19 (251)
CRISPR (11)
C-suite (42)
Cystic fibrosis (40)
Data (261)
Denatured (5)
Depression (1)
Diabetes (22)
Diagnostics (647)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (14)
Drug pricing (6)
Duchenne muscular dystrophy (6)
Earnings (5147)
Editorial (5)
Employer branding (2)
Employer resources (10)
Events (8259)
Executive appointments (110)
FDA (1604)
Featured Employer (4)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (159)
Gene editing (18)
Generative AI (4)
Gene therapy (33)
GLP-1 (53)
Government (449)
Guidances (5)
Healthcare (2594)
IgA nephropathy (4)
Immunology and inflammation (7)
Indications (5)
Infectious disease (266)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (8)
Intellectual property (10)
Interviews (13)
IPO (1150)
IRA (2)
Job creations (202)
Job search strategy (89)
Labor market (2)
Layoffs (29)
Leadership (2)
Legal (437)
Liver cancer (5)
Lung cancer (40)
Lymphoma (18)
Management (3)
Manufacturing (34)
MASH (5)
Medical device (1214)
Medtech (1215)
Mergers & acquisitions (1340)
Metabolic disorders (48)
Multiple sclerosis (1)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (349)
NextGen: Class of 2025 (884)
Non-profit (2420)
Northern California (250)
Obesity (25)
Opinion (24)
Ovarian cancer (11)
Pain (4)
Pancreatic cancer (6)
Parkinson's disease (49)
Partnered (3)
Patents (21)
Patient recruitment (8)
Peanut (9)
People (8250)
Pharmaceutical (4)
Phase I (1859)
Phase II (2590)
Phase III (2181)
Pipeline (107)
Podcasts (5)
Policy (6)
Postmarket research (220)
Preclinical (743)
Press Release (15)
Prostate cancer (14)
Psychedelics (1)
Radiopharmaceuticals (25)
Rare diseases (69)
Real estate (475)
Recruiting (2)
Regulatory (1688)
Reports (2)
Research institute (532)
Resumes & cover letters (14)
RSV (6)
Schizophrenia (8)
Series A (28)
Series B (17)
Sickle cell disease (8)
Southern California (178)
Special edition (1)
Sponsored (4)
Startups (503)
Supply chain (6)
United States (2115)
Vaccines (63)
Venture capitalists (4)
Webinars (1)
Weight loss (14)
Women's health (2)
Worklife (2)
Date
Today (12)
Last 7 days (68)
Last 30 days (337)
Last 365 days (3708)
2025 (731)
2024 (3855)
2023 (4404)
2022 (5383)
2021 (6325)
2020 (6267)
2019 (6169)
2018 (4675)
2017 (3201)
2016 (3300)
2015 (3453)
2014 (2443)
2013 (1853)
2012 (1898)
2011 (1980)
2010 (1503)
Location
Africa (88)
Alabama (2)
Alaska (2)
Arizona (9)
Arkansas (1)
Asia (2967)
Australia (579)
California (529)
Canada (159)
China (40)
Colorado (21)
Connecticut (55)
Delaware (15)
Europe (8073)
Florida (69)
Georgia (32)
Idaho (5)
Illinois (68)
India (3)
Indiana (29)
Iowa (2)
Japan (26)
Kansas (9)
Kentucky (6)
Maine (3)
Maryland (77)
Massachusetts (397)
Michigan (16)
Minnesota (23)
Missouri (16)
Montana (8)
Nebraska (6)
Nevada (6)
New Hampshire (8)
New Jersey (152)
New Mexico (4)
New York (173)
North Carolina (110)
North Dakota (1)
Northern California (250)
Ohio (25)
Oklahoma (1)
Oregon (3)
Pennsylvania (111)
Rhode Island (4)
South America (97)
South Carolina (2)
South Dakota (1)
Southern California (178)
Tennessee (4)
Texas (95)
Utah (23)
Virginia (10)
Washington D.C. (8)
Washington State (51)
West Virginia (1)
Wisconsin (3)
64,216 Results for "ewing marion kauffman foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ewing’s Sarcoma Market Size to Reach USD 78.2 Million by 2035, Impelled by Growing Research & Development Activities
January 30, 2025
·
10 min read
Business
Nereid Therapeutics Appoints Michael Kauffman as CEO
Nereid Therapeutics announced today that Michael Kauffman, M.D., Ph.D., has joined the company as President and Chief Executive Officer.
November 13, 2023
·
3 min read
BioForest
Gilead Sciences: Living with a Rare Blood Cancer: Marion’s Story
In her late 50s, Marion’s doctor found a cancerous wart that required an intense six weeks of radiation therapy, coupled with chemotherapy.
June 7, 2023
·
1 min read
Rapafusyn’s Rick Ewing Acknowledged with Dual Honors for Exceptional Achievements
Baltimore, MD – February 1, 2024 – Rapafusyn proudly announces the distinguished recognition of Dr. Rick Ewing, Vice President of Medicinal Chemistry, for his outstanding contributions to the realms of chemistry and biotechnology innovation.
February 5, 2024
·
2 min read
Press Releases
Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma
September 9, 2024
·
7 min read
Press Releases
Kaiser Foundation Health Plan, Kaiser Foundation Hospitals, and Risant Health report 2024 financial results
February 9, 2025
·
6 min read
Press Releases
Foundation Medicine Collaborates with Sumitomo Pharma America to Advance Investigational Treatment for Patients with Acute Leukemia with NPM1 Mutations or KMT2A Rearrangements Using the FoundationOne®Heme Platform
February 19, 2025
·
4 min read
Policy
Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
Salarius Pharmaceuticals, Inc. announces that it participated in a Type B End-of-Phase 2 meeting with the U.S. Food and Drug Administration to receive guidance regarding the development program for seclidemstat to treat Ewing sarcoma.
November 7, 2023
·
7 min read
Genetown
Foundation Medicine Launches RNA Sequencing Test, FoundationOne®RNA, in the U.S.
Foundation Medicine, Inc., announced the U.S. launch of FoundationOne®RNA, a tissue-based RNA sequencing test for the detection of cancer-related fusions across 318 genes.
May 21, 2024
·
7 min read
Drug Development
Inhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing Sarcoma
Inhibrx, Inc. announced preliminary efficacy and safety data from the Phase 1 trial of INBRX-109 in combination with Irinotecan and Temozolomide for the treatment of advanced or metastatic, unresectable Ewing sarcoma.
November 2, 2023
·
5 min read
1 of 6,422
Next
